- Home
- WIA vs HRTX Comparison
WIA vs HRTX Comparison
Compare WIA & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIA
- HRTX
- Stock Information
- Founded
- WIA 2003
- HRTX 1983
- Country
- WIA United States
- HRTX United States
- Employees
- WIA N/A
- HRTX N/A
- Industry
- WIA Trusts Except Educational Religious and Charitable
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- WIA Finance
- HRTX Health Care
- Exchange
- WIA Nasdaq
- HRTX Nasdaq
- Market Cap
- WIA 197.8M
- HRTX 203.5M
- IPO Year
- WIA N/A
- HRTX 1987
- Fundamental
- Price
- WIA $8.35
- HRTX $1.12
- Analyst Decision
- WIA
- HRTX Strong Buy
- Analyst Count
- WIA 0
- HRTX 2
- Target Price
- WIA N/A
- HRTX $4.50
- AVG Volume (30 Days)
- WIA 39.2K
- HRTX 2.2M
- Earning Date
- WIA 01-01-0001
- HRTX 11-04-2025
- Dividend Yield
- WIA 12.29%
- HRTX N/A
- EPS Growth
- WIA N/A
- HRTX N/A
- EPS
- WIA N/A
- HRTX N/A
- Revenue
- WIA N/A
- HRTX $155,097,000.00
- Revenue This Year
- WIA N/A
- HRTX $10.62
- Revenue Next Year
- WIA N/A
- HRTX $12.99
- P/E Ratio
- WIA N/A
- HRTX N/A
- Revenue Growth
- WIA N/A
- HRTX 12.60
- 52 Week Low
- WIA $7.56
- HRTX $1.00
- 52 Week High
- WIA $8.91
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- WIA 50.08
- HRTX 46.13
- Support Level
- WIA $8.26
- HRTX $1.01
- Resistance Level
- WIA $8.37
- HRTX $1.14
- Average True Range (ATR)
- WIA 0.06
- HRTX 0.07
- MACD
- WIA -0.00
- HRTX 0.01
- Stochastic Oscillator
- WIA 39.29
- HRTX 72.08
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.